DOI QR코드

DOI QR Code

A Case of Peritoneal Tuberculosis with Poncet's Disease in a Patient Treated with Infliximab

Infliximab으로 치료 받은 환자에서 발생한 결핵성 복막염과 동반된 Poncet's Disease 1예

  • Park, Hyo (Department of Internal Medicine, Eulji University School of Medicine) ;
  • Park, Chan-Woong (Department of Internal Medicine, Eulji University School of Medicine) ;
  • Kim, Ki-Bang (Department of Internal Medicine, Eulji University School of Medicine) ;
  • Lee, Min-Ji (Department of Internal Medicine, Eulji University School of Medicine) ;
  • Zeon, Seok-Jae (Department of Internal Medicine, Eulji University School of Medicine) ;
  • Shim, Seung-Cheol (Department of Internal Medicine, Eulji University School of Medicine) ;
  • Lim, Mi-Kyung (Department of Internal Medicine, Eulji University School of Medicine) ;
  • Sheen, Dong-Hyuk (Department of Internal Medicine, Eulji University School of Medicine)
  • 박효 (을지대학교 의과대학 내과학교실) ;
  • 박찬웅 (을지대학교 의과대학 내과학교실) ;
  • 김기방 (을지대학교 의과대학 내과학교실) ;
  • 이민지 (을지대학교 의과대학 내과학교실) ;
  • 전석재 (을지대학교 의과대학 내과학교실) ;
  • 심승철 (을지대학교 의과대학 내과학교실) ;
  • 임미경 (을지대학교 의과대학 내과학교실) ;
  • 신동혁 (을지대학교 의과대학 내과학교실)
  • Published : 2011.03.30

Abstract

Infliximab is a chimeric mouse/human monoclonal antibody against tumor necrosis factor-alpha (TNF-$\alpha$) that is used worldwide to treat rheumatic disease. However, the reactivation of tuberculosis, including extrapulmonary menifestation, is a severe side effect of anti-TNF-$\alpha$ treatment. Mycobacterium tubercluosis causes two forms of joint involvement, TB arthritis and Poncet's disease. Poncet's disease is a rare aseptic form of arthritis, known as reactive arthritis in tuberculosis. We encountered a case of tuberculous peritonitis with Poncet's disease in a 38-yearold man with a history of ankylosing spondylitis that was treated with infliximab. We report this case with a review of the literature.

저자들은 infliximab치료를 받은 강직성척추염 환자에서 유발된 결핵성 복막염을 진단받고 항결핵제를 복용중인 38세 남자에서 발생한 다발성 관절염을 관찰하고 강직성 척추염에 의한 말초 관절염과 결핵성 관절염을 감별하여 Poncet's disease로 진단하고 치료하여 증상의 호전을 보인 증례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

Keywords

References

  1. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344:907-16. https://doi.org/10.1056/NEJM200103223441207
  2. Cush JJ. Safety overview of new disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 2004;30: 237-55. https://doi.org/10.1016/j.rdc.2004.02.003
  3. Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 2007;34: 706-11.
  4. Kroot EJ, Hazes JM, Colin EM, Dolhain RJ. Poncet's disease: reactive arthritis accompanying tuberculosis. Two case reports and a review of the literature. Rheumatology (Oxford) 2007;46:484-9. https://doi.org/10.1093/rheumatology/kel268
  5. Dall L, Long L, Stanford J. Poncet's disease: tuberculous rheumatism. Rev Infect Dis 1989;11:105-7. https://doi.org/10.1093/clinids/11.1.105
  6. Hameed K, Karim M, Islam N, Gibson T. The diagnosis of Poncet's disease. Br J Rheumatol 1993;32:824-6. https://doi.org/10.1093/rheumatology/32.9.824
  7. Kwok SK, Park SH. Guidelines for Prevention of Tuberculosis in Patients with Rheumatoid Arthritis Treated with TNF-alpha Blockers. J Korean Rheum Assoc 2007;14:105- 11. https://doi.org/10.4078/jkra.2007.14.2.105
  8. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104. https://doi.org/10.1056/NEJMoa011110
  9. Poncet A. De la polyarthrite tuberculeuse deformante on pseudo-rheumatisme chronique tuberculeux. Congr Fr Chir 1897;2:732-4.
  10. Summers GD, Jayson MI. Does Poncet's disease exist? Rheumatol Rehabil 1980;19:149-50. https://doi.org/10.1093/rheumatology/19.3.149
  11. Lee HL, Lee IH, Son BK, Jung JH, Kim TH, Yang SC, et al. A case of Poncet's disease with tuberculosis of the intestine and lymph nodes. Korean J Med 2001;61:211-4.
  12. Park SS, Yun CY, Kang EH, Lee EY, Lee YJ, Lee EB,et al. A case of poncet's disease in a patient with pulmonary tuberculosis. J Korean Rheum Assoc 2010;17:183-7. https://doi.org/10.4078/jkra.2010.17.2.183
  13. Choi SW, Ahn JJ, Hwang YT, Koh SH, Cho SD. A case of tuberculous arthritis following the use of etanercept. Korean J Intern Med 2009;24:397-401. https://doi.org/10.3904/kjim.2009.24.4.397
  14. Klippel JH, Stone JH, Crofford LJ, White PH. Primer on the rheumatic diseases. 13th ed. p.193-9, New York, Springer, 2008.
  15. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/ Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62. https://doi.org/10.1164/rccm.167.4.603

Cited by

  1. 결절홍반을 동반한 폐결핵환자에 나타난 Poncet병 1예 vol.71, pp.3, 2011, https://doi.org/10.4046/trd.2011.71.3.221
  2. Tuberculous Peritonitis in a Patient with Rheumatoid Arthritis Treated with Infliximab vol.18, pp.4, 2011, https://doi.org/10.4078/jrd.2011.18.4.320
  3. A Case of Peritoneal Tuberculosis Developed after Infliximab Therapy for Refractory RA vol.73, pp.4, 2012, https://doi.org/10.4046/trd.2012.73.4.234